Mission Therapeutics has divested MTX652, a Phase 2-ready selective USP30 inhibitor for Acute Kidney Injury (AKI), to ASX-listed renal specialist Dimerix Limited (ASX: DXB)Mission will receive up to U ...
Turkish Cargo is taking the next major step in expanding SMARTIST, its cutting-edge cargo hub at Istanbul Airport. With this ...
13 小时Opinion
Fifty years on, Olympic Stadium still casts a shadow over Montreal’s architecture. Will a ...
The Bellechasse bus garage, which doubles as a public space, suggests that the ambition and confidence that Montreal felt in ...
Image courtesy of Changi Airport Group. Changi Airport Group (CAG) has awarded Nakano Singapore (Pte) Ltd a contract to ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果